Birben, E. Et Al. 2010. New roles for a serine protease inhibitor, Kazal-Type 5 (SPINK5) in asthma. 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (London, Canada), 548-549.

Birben, E., Karaaslan, C., Turgutoglu, N., Yavuz, S., Sahiner, U., Sackesen, C., ... Kalayci, O.(2010). New roles for a serine protease inhibitor, Kazal-Type 5 (SPINK5) in asthma . 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.548-549). London, Canada

Birben, E. Et Al. "New roles for a serine protease inhibitor, Kazal-Type 5 (SPINK5) in asthma," 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 2010

Birben, E. Et Al. "New roles for a serine protease inhibitor, Kazal-Type 5 (SPINK5) in asthma." 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , London, Canada, pp.548-549, 2010

Birben, E. Et Al. (2010) . "New roles for a serine protease inhibitor, Kazal-Type 5 (SPINK5) in asthma." 29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , London, Canada, pp.548-549.

@conferencepaper{conferencepaper, author={E. Birben Et Al. }, title={New roles for a serine protease inhibitor, Kazal-Type 5 (SPINK5) in asthma}, congress name={29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={London}, country={Canada}, year={2010}, pages={548-549} }